JOSÉ LUIS
PEDRAZ MUÑOZ
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (3)
2022
-
One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics
RSC Advances, Vol. 12, Núm. 43, pp. 27963-27969
2021
2018
-
Tunable injectable alginate-based hydrogel for cell therapy in Type 1 Diabetes Mellitus
International Journal of Biological Macromolecules, Vol. 107, Núm. PartA, pp. 1261-1269